888 filings
Page 10 of 45
424B5
ABUS
Arbutus Biopharma Corp
7 Aug 20
Prospectus supplement for primary offering
4:54pm
424B5
ABUS
Arbutus Biopharma Corp
7 Aug 20
Prospectus supplement for primary offering
4:48pm
10-Q
2020 Q2
ABUS
Arbutus Biopharma Corp
Quarterly report
7 Aug 20
4:24pm
8-K
ABUS
Arbutus Biopharma Corp
7 Aug 20
Arbutus Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:34am
4
McElhaugh Michael J.
27 Jul 20
Arbutus Biopharma / Michael J. McElhaugh ownership change
5:27pm
8-K
ABUS
Arbutus Biopharma Corp
24 Jul 20
Other Events
12:00am
CT ORDER
ABUS
Arbutus Biopharma Corp
23 Jul 20
Confidential treatment order
12:56pm
SC 13G
ABUS
Arbutus Biopharma Corp
16 Jul 20
Arbutus Biopharma / MORGAN STANLEY ownership change
4:22pm
S-8
ABUS
Arbutus Biopharma Corp
24 Jun 20
Registration of securities for employees
4:22pm
8-K
ABUS
Arbutus Biopharma Corp
1 Jun 20
Departure of Directors or Certain Officers
5:12pm
4
ABUS
Arbutus Biopharma Corp
1 Jun 20
Arbutus Biopharma / James R Meyers ownership change
5:04pm
4
ABUS
Arbutus Biopharma Corp
1 Jun 20
Arbutus Biopharma / RICHARD C HENRIQUES JR ownership change
5:03pm
4
Collier William H.
1 Jun 20
Arbutus Biopharma / William H. Collier ownership change
5:02pm
4
Torti Frank
1 Jun 20
Arbutus Biopharma / Frank Torti ownership change
5:01pm
4
Cheng Andrew
1 Jun 20
Arbutus Biopharma / Andrew Cheng ownership change
4:58pm
4
ABUS
Arbutus Biopharma Corp
1 Jun 20
Arbutus Biopharma / KEITH S MANCHESTER ownership change
4:57pm
4
Burgess Daniel D
1 Jun 20
Arbutus Biopharma / DANIEL D BURGESS ownership change
4:56pm
8-K
ABUS
Arbutus Biopharma Corp
18 May 20
90 mg single-dose and 60 mg multi-dose cohorts initiated with data expected in the second half of 2020
5:02pm
10-Q
2020 Q1
ABUS
Arbutus Biopharma Corp
Quarterly report
11 May 20
4:07pm
8-K
ABUS
Arbutus Biopharma Corp
11 May 20
Arbutus remains on track to achieve its key 2020 objectives despite COVID-19 challenges
8:29am